Antibacterial and mutagenic activity of inhaled bronchodilators on the respiratory pathogen Haemophilus influenzae

Détails

ID Serval
serval:BIB_5511D314773F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Antibacterial and mutagenic activity of inhaled bronchodilators on the respiratory pathogen Haemophilus influenzae
Périodique
Respiratory Medicine
Auteur⸱e⸱s
Powell  M., Majcherczyk  P. A., Williams  J. D.
ISSN
0954-6111 (Print)
Statut éditorial
Publié
Date de publication
07/1990
Volume
84
Numéro
4
Pages
325-30
Notes
In Vitro
Journal Article --- Old month value: Jul
Résumé
The U.K. prevalence of non-beta-lactamase-mediated resistance to ampicillin among Haemophilus influenzae reached 4% in 1986. The majority (70%) of isolates of this type come from sputa of patients with chronic obstructive airways disease. This study investigated whether bronchodilator drugs delivered directly to the respiratory tract have any antibacterial activity and/or play a role in promoting selection of organisms with this type of resistance. Antibacterial activity was detected in two out of six pharmaceutical preparations for nebulization examination but was entirely attributable to the preservative (benzalkonium chloride) in them. Exposure of ampicillin-susceptible H. influenzae (minimum inhibitory concentration 0.25 mg l-1) to concentrations of salbutamol, fenoterol and beclomethasone theoretically attainable in vivo resulted, after 48 h, in isolation of colonies with reduced susceptibility to ampicillin (minimum inhibitory concentration 1-4 mg l-1) but reversion to beta-lactam susceptibility occurred following serial subculture on chocolate agar. Organisms with stable reduced susceptibility to ampicillin were obtained when exposure to one of these three bronchodilators in broth was followed by serial subculture on agar containing the same preparations at equivalent concentrations and when the period of exposure to salbutamol at 100 mg l-1 in broth was extended to 5 days. The occurrence of these phenomena in vivo might be contributing to failures in treatment of exacerbations with ampicillin and to an increasing prevalence of beta-lactamase-negative, ampicillin-resistant H. influenzae.
Mots-clé
Ampicillin/pharmacology Ampicillin Resistance Bronchodilator Agents/*pharmacology Haemophilus influenzae/*drug effects/genetics/growth & development Microbial Sensitivity Tests Mutation
Pubmed
Web of science
Création de la notice
24/01/2008 13:54
Dernière modification de la notice
20/08/2019 14:09
Données d'usage